Avecho Appoints Subaraj Subramaniam As CFO
Closing price · 2026-10-27: $0.014 · +0.00%
Avecho Biotechnology has appointed Subaraj Subramaniam as chief financial officer, effective immediately, replacing Melanie Leydin, who has served the company since 2018. Subramaniam has more than 15 years’ accounting experience, including over seven years supporting ASX-listed companies.